Company / Current Assets per Share
4D Molecular Therapeutics, Inc. Current Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$9.02
FY2025
5-year range
$6.84 / $10.10
FY2021-FY2025
Trend
-10.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
9.02 in FY2025 with a 5-year CAGR of -30.2%.
Remained stable around $9.02 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +9.7%
- 5-Year CAGR
- -30.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets per share decreased 10.7% year-over-year.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.26 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.02 | -10.7% |
| FY2024 | $10.10 | +11.1% |
| FY2023 | $9.09 | +32.8% |
| FY2022 | $6.84 | -28.8% |
| FY2021 | $9.60 | -82.4% |
| FY2020 | $54.58 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026